Patrick Julier
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 5
- Colorectal Cancer Treatments and Studies 5
- Cancer Treatment and Pharmacology 1
-
- Inflammatory mediators and NSAID effects 3
- Co-authors
- Rachel S. Midgley (4 shared papers)Janet Audrey Dunn (3 shared papers)Michael J. S. Langman (2 shared papers)Christopher C. McConkey (2 shared papers)Elaine C Johnstone (3 shared papers)Rachel S. Kerr (3 shared papers)David J. Kerr (1 shared paper)Andrew C Stanley (1 shared paper)
- Journals
- Annals of Oncology (4 papers)Journal of Clinical Oncology (2 papers)The Lancet Rheumatology (2 papers)The Lancet Oncology (2 papers)Trials (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Patrick Julier
14 papers receiving 998 citations
Peers
Comparison fields: 5 of 70
- Oncology 512
- Pulmonary and Respiratory Medicine 241
- Cancer Research 106
- Pathology and Forensic Medicine 109
- Gastroenterology 33
Countries citing papers authored by Patrick Julier
This map shows the geographic impact of Patrick Julier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Julier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Julier more than expected).
Fields of papers citing papers by Patrick Julier
This network shows the impact of papers produced by Patrick Julier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Julier. The network helps show where Patrick Julier may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Julier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 271 | |
| 2 | 2014 | 210 | |
| 3 | 2016 | 122 | |
| 4 | 2007 | 110 | |
| 5 | 2014 | 92 | |
| 6 | 2010 | 85 | |
| 7 | 2022 | 61 | |
| 8 | 2022 | 17 | |
| 9 | VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION | 2008 | 15 |
| 10 | 2012 | 14 | |
| 11 | 2023 | 9 | |
| 12 | 2014 | 7 | |
| 13 | 2022 | 5 | |
| 14 | 2012 | 2 | |
| 15 | 2024 | 1 |
About Patrick Julier
Patrick Julier is a scholar working on Oncology, Pharmacology, Infectious Diseases, Toxicology and Biochemistry, having authored 15 papers that have together received 1.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Inflammatory mediators and NSAID effects (3 papers), Esophageal Cancer Research and Treatment (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Cancer Genomics and Diagnostics (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Oncology (512 citations), Pulmonary and Respiratory Medicine (241 citations), Cancer Research (106 citations), Pathology and Forensic Medicine (109 citations) and Gastroenterology (33 citations). Patrick Julier has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Rachel S. Midgley, Janet Audrey Dunn, Michael J. S. Langman, Christopher C. McConkey, Elaine C Johnstone, Rachel S. Kerr, David J. Kerr, Andrew C Stanley, Enric Domingo and Francesco Pezzella. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Lancet Rheumatology, The Lancet Oncology and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.